The project, subsidised by the CDTI with 5.4 million euros and a final budget of 7.4 million euros, was submitted to the call for Science and Innovation Missions in the framework of the Recovery, Transformation and Resilience Plan. Madrid, 2 February 2022. The OLIGOFASTX project, led by Sylentis, S.A., “Grupo PharmaMar” (MSE:PHM), brings together 7 […]